Evidence map›Paper›PMID 42602588›Full record

ArticleIDCases2026

Now you see me, now you don't: A vanishing papillomatous CMV pseudotumor in an immunocompetent host.

Nelson O Onyango

Abstract readCase Reports
In one paragraph

Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Nelson O OnyangoDepartment of Medicine, Division of Hospital Internal Medicine, Mayo Clinic, Phoenix, AZ, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cytomegalovirus (CMV) is a viral infection that not uncommonly affects immunosuppressed patients, such as patients with HIV, those on chemotherapy, and transplant recipients. We present an unusual case of CMV manifesting as a pseudotumor in an immunocompetent patient. Case presentation: A 73-year-old woman had been trapped for seven days under her belongings after a fall before being found. She was admitted for septic shock secondary to an Conclusion: CMV typically presents as a GI infection in immunosuppressed individuals. Risk factors include advanced age, renal failure, sepsis, malnutrition, and trauma. Malnutrition reduces T-lymphocyte counts, increasing susceptibility to infection. Pathogenesis likely involves viral proliferation in the endothelium, leading to vasculitis, thrombosis, and local ulceration. CMV seropositivity is high in immunocompetent adults. However, active disease results from reactivation after a latent phase. Biopsy is the gold standard for diagnosis and shows "owl's eyes," which are basophilic intranuclear inclusions; serology, cultures, and antigen tests can also be used. Treatment includes antivirals such as ganciclovir, foscarnet, and cidofovir. Previous studies have demonstrated that CMV-induced inflammatory tissue, which appears as tumor-like masses, has completely resolved with antiviral therapy. In our patient, bleeding stopped after initiation of therapy, and her follow-up colonoscopy to evaluate the resolution of her pseudotumor confirmed regression of the tumor.

Indexed as

Case ReportCytomegalovirus (CMV)GanciclovirGastrointestinal BleedImmunocompetentImmunosuppressedIntranuclear InclusionsPapillomaPseudotumorValganciclovir

Identifiers

PMID42602588
PMCPMC13475237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.